Inventor · disambiguated record
Magnus Doverskog
Also filed as: DOVERSKOG MAGNUS
5 granted patents·3 pending applications·7 citations·filing 2015–2022
72Inventor score
Files withUMECRINE COGNITION AB8
Top patents by PatentIndex Score
8 records- 0180US10603326B2Pharmaceutical formulation of 3α-ethynyl-3β-hydroxyandrostan-17-one oximeUMECRINE COGNITION AB·Filed 2019·Granted Mar 31, 2020·2 cites·27 claims
- 0276US11123351B2Pharmaceutical formulation of 3-alpha-ethynyl-3-beta-hydroxyandrostan-17-one oximeUMECRINE COGNITION AB·Filed 2020·Granted Sep 21, 2021·1 cites·22 claims
- 0374US10342804B2Steroid compound for use in the treatment of hepatic encephalopathyUMECRINE COGNITION AB·Filed 2017·Granted Jul 9, 2019·2 cites·20 claims
- 0474US9801894B2Steroid compound for use in the treatment of hepatic encephalopathyUMECRINE COGNITION AB·Filed 2016·Granted Oct 31, 2017·2 cites·27 claims
- 0560US2023134958A1New medical treatmentUMECRINE COGNITION AB·Filed 2022·Application pending·0 cites
- 0652US2024216394A1Golexanolone for use in the treatment of fatigue or cognitive impairment in liver disease patientsUMECRINE COGNITION AB·Filed 2022·Application pending·0 cites
- 0748US10278977B2Methods for treating hypersomnolenceUMECRINE COGNITION AB·Filed 2017·Granted May 7, 2019·0 cites·10 claims
- 0839US2016339040A1Steroid compound for use in the treatment of hepatic encephalopathyUMECRINE COGNITION AB·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Magnus Doverskog files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →